1 2 3 4 5
читать далее ... Surgery). J. Am. Coll. Cardiol. 1999; 34: 1262-1347. 14. Kirklin L. W., Akins C. W., Blackstone E. N. et al. Guidelines and indication for coronary artery bypass graft surgery. A rapport of the American Heart Association / American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). J. Am. Coll. Cardiol. 1991; 17: 543— 560. 15. Chesebro J. H., Knatterud G., Roberts R. et al. Thrombolysis in Myocardial Infarction (T1M1) trial. Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142—154.т 16. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360 (9326): 7-22. 17. European Atherosclerosis Society. Prevention of coronary heart disease — scientific background and new clinical guidelines. Nutr., Metab. Cardiovasc. Dis. 1992; 2: 113-156. 18. Kannel W. В., Wolf P. A., Garrison R. J. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. In: Framingham heart study — N1H-1987. Publ. NIH-87, — 2703. 19. Stamler J. Established major coronary risk factors. In: Marmot M., Elliott P., eds. Coronary heart disease epidemiology. Oxford: Oxford University Press; 1996. 35—62.Источник: Беленький Д.И. и др. Клиническая медицина. 2006. №5. С.63-65